ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0122

Documentation of Social Determinants of Health Among Individuals with Systemic Rheumatic and Musculoskeletal Diseases

Sciaska Ulysse, Mia Chandler, Leah Santacroce, Tianrun Cai, Katherine Liao and Candace Feldman, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Disparities, Osteoarthritis, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Social determinants of health (SDoH), “the conditions in which people are born, grow, work, live, and age” (World Health Organization, 2022), directly influence health inequities. In our multihospital system, SDoH are not systematically assessed as part of routine rheumatic disease care. We studied patients with rheumatic conditions enrolled in an integrated care management program (iCMP), which provides care coordination for medically and/or psychosocially complex patients. We aimed to understand the documentation of SDoH-related needs during iCMP enrollment in electronic medical record (EMR) notes and whether the prevalence differed by rheumatic condition.

Methods: Among 20,395 adults (≥18 years) with ≥1 ICD-9/10 code for a systemic rheumatic condition, crystalline arthritis or osteoarthritis enrolled in iCMP between 1/1/12-10/18/21, we randomly selected 401 individuals. We excluded 18 individuals with insufficient EMR data. We reviewed the literature (SU, MC) to develop a set of SDoH-related terms related to financial needs, food insecurity, housing instability, transportation, and medication access and the most frequently used phrases were used to develop the standard operating procedure for the chart reviews. Charts were manually reviewed (SU, MC, CF) and SDoH phrases were extracted from EMR notes written by physicians, nurses, care coordinators, social workers, and nutritionists during iCMP enrollment. Patients were classified by whether they had any indication of documented SDoH-related needs. We used multivariable logistic regression to estimate the odds of having ≥1 SDoH need by demographic factors and rheumatic condition.

Results: Among 383 patients, the mean (SD) age was 72.2 (13.4) years, 61% were female, 79% were White, 10% were Black, and 80% were non-Hispanic (Table 1). The mean (SD) period of iCMP enrollment was 3.3 (2.4) years. There were 111 patients (29%) with a systemic rheumatic disease, 96 (25%) with crystalline arthritis, and 176 (46%) with osteoarthritis without systemic or crystalline disease. Of the 383 charts reviewed, 45% contained documentation of ≥1 SDoH need. Overall, 105 individuals (27%) had evidence of financial needs, 77 (20%) transportation needs, 63 (16%) food insecurity, 18 (5%) housing instability, and 21 (5%) medication access challenges, with variation by rheumatic condition (Figure 1). In the multivariable model, the odds of having ≥1 SDoH need was 2.85 times higher (95% CI 1.28-6.80) for Black vs. White individuals and 3.44 times higher (95% CI 1.17-10.19) for Medicaid vs. Commercial insurance beneficiaries (Table 2).

Conclusion: Nearly half of this population of complex care patients with rheumatic conditions had SDoH needs documented in EMR notes with the highest overall percentage among individuals with osteoarthritis. Higher burden was noted among Black individuals and Medicaid beneficiaries, however SDoH documentation was infrequently structured or standardized in notes, and differences may, in part, reflect ascertainment bias. Further efforts are needed to incorporate SDoH screening into routine rheumatology care, enabling integration of SDoH factors into both clinical care and research.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Ulysse, None; M. Chandler, None; L. Santacroce, None; T. Cai, None; K. Liao, None; C. Feldman, AtlasBio, Pfizer Pharmaceuticals, BMS Foundation, Health Resources in Action, Illumina, Mestag Therapeutics, Elsevier.

To cite this abstract in AMA style:

Ulysse S, Chandler M, Santacroce L, Cai T, Liao K, Feldman C. Documentation of Social Determinants of Health Among Individuals with Systemic Rheumatic and Musculoskeletal Diseases [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/documentation-of-social-determinants-of-health-among-individuals-with-systemic-rheumatic-and-musculoskeletal-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/documentation-of-social-determinants-of-health-among-individuals-with-systemic-rheumatic-and-musculoskeletal-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology